XML 70 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity, Stock Option and Restricted Shares (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
2000 Employee Option Plan        
Stock-Based Compensation        
Options exercisable period 10 years      
2009 Employee Option Plan        
Stock-Based Compensation        
Number of additional stock options that will be granted (in shares) 0      
Options ratable vesting period 5 years      
Options exercisable period 10 years      
2017 Employee Option Plan        
Stock-Based Compensation        
Common Stock reserved for issuance 30,000,000      
Shares available for the granting of additional stock options 22,991,400      
Options ratable vesting period 5 years      
Options exercisable period 10 years      
2004 Directors Option Plan        
Stock-Based Compensation        
Options exercisable period 10 years      
Stock Options        
Stock option activity        
Options outstanding at the beginning of the period (in shares) 32,266,391 31,136,475 27,787,920  
Options granted (in shares) 7,029,600 7,560,450 6,490,200  
Options exercised (in shares) (5,773,287) (5,703,254) (2,718,745)  
Options forfeited (in shares) (300,340) (727,280) (422,900)  
Options outstanding at the end of the period (in shares) 33,222,364 32,266,391 31,136,475 27,787,920
Vested and non-vested options expected to vest at the end of the period (in shares) 31,214,883      
Exercisable at the end of the period (in shares) 13,621,924      
Weighted Average Exercise Price        
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) $ 44.14 $ 37.62 $ 31.60  
Weighted average exercise price, options granted (in dollars per share) 72.98 57.72 57.85  
Weighted average exercise price, options exercised (in dollars per share) 31.87 25.80 23.71  
Weighted average exercise price, options forfeited (in dollars per share) 55.16 50.17 41.73  
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) 52.27 $ 44.14 $ 37.62 $ 31.60
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share) 51.61      
Weighted average exercise price, exercisable (in dollars per share) $ 39.48      
Weighted Average Remaining Contractual Term        
Weighted average remaining contractual term of options outstanding 7 years 18 days 7 years 11 days 6 years 11 months 1 day 7 years 1 month 2 days
Weighted average remaining contractual term of options vested options and non-vested expected to vest 6 years 11 months 16 days      
Weighted average remaining contractual term of options exercisable 5 years 4 months 24 days      
Aggregate Intrinsic Value        
Aggregate intrinsic value of options outstanding $ 1,180.3      
Aggregate intrinsic value of options, vested and non-vested options expected to vest 1,129.8      
Aggregate intrinsic value of options exercisable $ 658.2      
Status of the Company's non-vested options and changes during the year        
Non-vested options at the beginning of the period (in shares) 18,725,570      
Options granted (in shares) 7,029,600 7,560,450 6,490,200  
Non-vested options, options vested (in shares) (5,854,390)      
Non-vested options, options forfeited (in shares) (300,340)      
Non-vested options at the end of the period (in shares) 19,600,440 18,725,570    
Weighted Average Fair Value at Grant Date        
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) $ 7.99      
Weighted average fair value at grant date, options granted (in dollars per share) 8.78 $ 7.39 $ 8.47  
Weighted average fair value at grant date, options vested (in dollars per share) 7.91      
Weighted average fair value at grant date, options forfeited (in dollars per share) 8.10      
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) $ 8.29 $ 7.99    
Fair Value at Grant Date        
Total intrinsic value of stock options exercised (in dollars) $ 268.7 $ 197.2 $ 88.1  
Total fair value of stock options vested (in dollars) 46.3 $ 43.1 $ 39.9  
Total compensation cost related to non-vested options not yet recognized (in dollars) $ 120.3      
Weighted average expected amortization period 3 years 3 months 18 days      
Restricted Shares | 2012 Directors Restricted Stock Plan        
Stock-Based Compensation        
Shares available for the granting of additional stock options 124,164      
Restricted share activity        
Restricted shares outstanding at the beginning of the period (in shares) 16,905 17,256 18,340  
Restricted shares granted (in shares) 12,905 16,905 17,948  
Shares vested and issued (in shares) (16,905) (17,256) (19,032)  
Restricted shares outstanding at the end of the period (in shares) 12,905 16,905 17,256 18,340
Fair Value at Grant Date        
Fair value at the grant date, restricted shares outstanding at the beginning of the period (in dollars per share) $ 57.99 $ 57.97 $ 47.72  
Fair value of restricted shares vested and issued (in dollar per share) 57.99 57.97 47.98  
Fair value of restricted shares granted (in dollars per share) 73.25 57.99 57.85  
Fair value at the grant date, restricted shares outstanding at the end of the period (in dollars per share) $ 73.25 $ 57.99 $ 57.97 $ 47.72
Weighted Average Remaining Amortization Term (in years) 4 months 13 days 4 months 17 days 4 months 21 days 4 months 21 days
Total fair value of restricted share awards vested (in dollars) $ 1.0 $ 1.0 $ 0.9  
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars) $ 0.4      
Weighted average expected amortization period 4 months 13 days